| URN | urn:agi-llid:2 |
|---|---|
| Total Entities | 0 |
| Connectivity | 1096 |
| Name | A2m |
| Description | alpha-2-macroglobulin |
| Notes | plays a role in acute phase response; activated form induces a decrease in N-methyl-D-aspartate (NMDA) mediated calcium signaling [RGD] |
| GO Molecular Function | peptidase inhibitor activity |
|---|---|
| endopeptidase inhibitor activity | |
| serine-type endopeptidase inhibitor activity | |
| growth factor binding | |
| enzyme binding | |
| protease binding | |
| tumor necrosis factor binding | |
| interleukin-1 binding | |
| interleukin-8 binding |
| GO Cellular Component | extracellular region |
|---|---|
| platelet alpha granule lumen | |
| cytosol | |
| extracellular space | |
| extracellular vesicular exosome |
| GO Biological Process | female pregnancy |
|---|---|
| negative regulation of complement activation, lectin pathway | |
| blood coagulation, intrinsic pathway | |
| blood coagulation | |
| platelet activation | |
| stem cell differentiation | |
| small GTPase mediated signal transduction | |
| regulation of small GTPase mediated signal transduction | |
| platelet degranulation | |
| response to nutrient | |
| response to carbon dioxide | |
| response to glucocorticoid | |
| response to wounding | |
| inflammatory response | |
| acute-phase response | |
| negative regulation of peptidase activity | |
| negative regulation of endopeptidase activity |
| Pathway | Extracellular Matrix Turnover |
|---|---|
| Mechanism of Amyloid beta Clearance | |
| Proteins Involved in Pathogenesis of Alzheimer's Disease | |
| Traffic and Degradation of Extracellular Amyloid beta in Alzheimer's Disease | |
| IL6 Expression Targets | |
| IL11 Expression Targets | |
| GH1-GHR/NF-kB/ELK-SRF/MYC Expression Targets | |
| PRL-GHR/STAT Expression Targets | |
| CSH1-GHR Expression Targets | |
| PRL-PRLR Expression Targets | |
| CSH1-PRLR Expression Targets | |
| IFNG-IFNR Expression Targets | |
| HGF/STAT Expression Targets | |
| Insulin/STAT Expression Targets | |
| FGF2/STAT Expression Targets | |
| TNF/NF-kB Expression Targets | |
| transforming growth factor-beta Smad dependent signaling pathway | |
| kallikrein-kinin cascade pathway | |
| transforming growth factor-beta Smad dependent signaling pathway | |
| altered transforming growth factor-beta Smad dependent signaling pathway | |
| transforming growth factor-beta Smad dependent signaling pathway | |
| kallikrein-kinin cascade pathway |
| Group | female pregnancy |
|---|---|
| negative regulation of complement activation, lectin pathway | |
| blood coagulation, intrinsic pathway | |
| blood coagulation | |
| platelet activation | |
| stem cell differentiation | |
| small GTPase mediated signal transduction | |
| regulation of small GTPase mediated signal transduction | |
| platelet degranulation | |
| response to nutrient | |
| response to carbon dioxide | |
| response to glucocorticoid | |
| response to wounding | |
| inflammatory response | |
| acute-phase response | |
| peptidase inhibitor activity | |
| endopeptidase inhibitor activity | |
| serine-type endopeptidase inhibitor activity | |
| negative regulation of peptidase activity | |
| negative regulation of endopeptidase activity | |
| growth factor binding | |
| enzyme binding | |
| protease binding | |
| tumor necrosis factor binding | |
| interleukin-1 binding | |
| interleukin-8 binding | |
| extracellular region | |
| platelet alpha granule lumen | |
| cytosol | |
| extracellular space | |
| extracellular vesicular exosome | |
| Secreted proteins | |
| Biofluids assayable substances |
| LocusLink ID | 2 |
|---|---|
| 232345 | |
| 24153 |
| Cell Localization | Secreted |
|---|---|
| Extracellular |
| GO ID | 0019899 |
|---|---|
| 0019838 | |
| 0019966 | |
| 0019959 | |
| 0002020 | |
| 0004867 | |
| 0043120 | |
| 0007596 | |
| 0007597 | |
| 0001869 | |
| 0030168 | |
| 0002576 | |
| 0051056 | |
| 0007264 | |
| 0048863 | |
| 0005829 | |
| 0005576 | |
| 0005615 | |
| 0070062 | |
| 0031093 | |
| 0004866 | |
| 0030414 | |
| 0007565 | |
| 0010951 | |
| 0010466 | |
| 0006953 | |
| 0006954 | |
| 0010037 | |
| 0051384 | |
| 0007584 | |
| 0009611 | |
| 0005102 | |
| 0042221 | |
| 0051260 | |
| 0005737 | |
| 0005634 | |
| 0005515 | |
| 0008320 | |
| 0017114 | |
| 0006886 | |
| 0019955 | |
| 0050750 | |
| 0051262 |
| Alias | A2MD |
|---|---|
| CPAMD5 | |
| FWP007 | |
| S863-7 | |
| alpha-2-macroglobulin | |
| alpha-2-M | |
| C3 and PZP-like alpha-2-macroglobulin domain-containing protein 5 | |
| A2mp | |
| alpha-2-macroglobulin-P | |
| Mam | |
| A2m1 | |
| A2maa | |
| A2MAC1 | |
| A2m | |
| alpha-2-macroglobulin of pregnancy | |
| DKFZp779b086 | |
| MGC114358 | |
| RATA2MAC I | |
| RATA2MAC1 | |
| S863 7 | |
| S863(7) | |
| S8637 | |
| A2M of pregnancy | |
| A2-macroglobulin of pregnancy | |
| a macroglobulin | |
| alpha 2 macroglobin | |
| alpha macroglobulin | |
| alpha-macroglobulins | |
| macroglobulin a2 | |
| macroglobulin alpha | |
| macroglobulin alpha 2 | |
| A2(MG) | |
| A(2)MG | |
| A2-m | |
| A2MAC I | |
| A(2)M | |
| a2-macroglobulin | |
| A2MG | |
| A-2MG | |
| A2-MG | |
| A2MG_HUMAN | |
| alpha(1)-inhibitor 3, variant I | |
| Mug I | |
| Mug1 | |
| murinoglobulin 1 | |
| murinoglobulin I | |
| Alpha-2-macroglobulin precursor | |
| murinoglobulin II | |
| murinoglobulin 2 | |
| Mug2 | |
| alpha 2M | |
| Alpha-2-macroglobulin precursor (Alpha-2-M) | |
| OVOSTATIN PRECURSOR (OVOMACROGLOBULIN) | |
| 60 bp gap between fragment 2 and fragment III | |
| 60 bp gap between fragment 2 and fragment 3 | |
| AI893533 | |
| A-2M | |
| alpha 2-macroglobulin |
| Mouse chromosome position | 6 57.49 cM |
|---|---|
| 6 61.7 cM |
| OMIM ID | 103950 |
|---|---|
| 614036 | |
| 104300 |
| Rat chromosome position | 4q42 |
|---|
| Hugo ID | 7 |
|---|
| Human chromosome position | 12p13.31 |
|---|---|
| 12p13.3-p12.3 |
| Swiss-Prot Accession | P01023 |
|---|---|
| Q6GQT1 | |
| P06238 | |
| E9QMQ7 | |
| Q811S0 | |
| Q13677 | |
| Q59F47 | |
| Q5QTS0 | |
| Q68DN2 | |
| Q6PIY3 | |
| Q6PN97 | |
| Q9BQ22 | |
| Q5D178 | |
| Q5D1M8 | |
| Q5FX35 | |
| Q63335 | |
| Q6LDG8 | |
| Q6LDR4 | |
| Q4FZY3 |
| PIR ID | A94033 |
|---|---|
| A26122 |
| Unigene ID | Hs.212838 |
|---|---|
| Mm.30151 | |
| Rn.225884 | |
| Rn.109457 |
| KEGG ID | hsa:2 |
|---|---|
| mmu:232345 | |
| rno:24153 |
| Swiss-Prot ID | A2MP_MOUSE |
|---|---|
| A2MG_HUMAN | |
| A2MG_RAT |
| Ensembl ID | ENSG00000175899 |
|---|---|
| ENSP00000323929 | |
| ENST00000318602 | |
| ENSMUSG00000030111 | |
| ENSMUSP00000032203 | |
| ENSMUST00000032203 | |
| ENSRNOG00000028896 | |
| ENSRNOP00000019346 | |
| ENSRNOT00000019346 |
| Homologene ID | 37248 |
|---|
| Organism | Homo sapiens |
|---|---|
| Mus musculus | |
| Rattus norvegicus |
| MGI ID | 2449119 |
|---|
| RGD ID | 2004 |
|---|
| MedScan ID | 2 |
|---|
| IPI ID | IPI00454052 |
|---|---|
| IPI00478003 | |
| IPI00392886 | |
| IPI00789547 | |
| IPI00796830 | |
| IPI00795565 | |
| IPI00878729 | |
| IPI00782403 |